Article
Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency.
Internal medicine (Tokyo, Japan) - 15 May 2022
Tamura Hotaka, Nakashima Koji, Uchiyama Naomi, Ogawa Souichiro, Hatada Hiroshi, Yoshida Naoki, Uchida Keisuke, Ozono Yoshinori, Tanaka Hiroyuki, Yamamto Koji, Kawakami Hiroshi
Abstract excerpt
Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of a 60-year-old man with short bowel syndrome who developed hematochezia due to panitumumab-induced colitis with vitamin K deficiency during third-line chemotherapy. The cause of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.